LATEST ALERTS
The countries analysed in this report were specifically selected due to their recent regulatory developments in medical and/or industrial cannabis. These include Eswatini, Ghana, Lesotho, Malawi, Rwanda, Uganda, Zambia and Zimbabwe
This report provides a detailed overview of the regulatory framework in place in Morocco for hemp, cannabis and CBD
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries
This report covers the current regulatory regime for hemp, CBD and cannabis in South Africa, including the regimes for medical and recreational cannabis
The CBD industry navigates a complex and changing regulatory landscape across the world, with parts of the industry operating in a grey area. This is particularly the case for one of the most popular product categories on the market: edibles
The regulatory landscape for CBD products varies across the world and constantly changing, making compliance a potential minefield. This report provides an overview of the current legal status of CBD cosmetics in key markets around the world
While cannabis and hemp are controlled substances in South Africa, most finished CBD products are probably legal without a licence – as long as they meet certain conditions
Cannabis and CBD are controlled substances in South Africa. Our snapshot gives you the details of what may be allowed and what is not
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
